Abstract
(Int J Obstet Anesth. 2021;46:102972) Preeclampsia is associated with increased incidence of thrombocytopenia (TCP) and coagulopathy, causing concern about obstetric hemorrhage [postpartum hemorrhage (PPH)] and spinal-epidural hematoma with neuraxial procedures. In the absence of other contraindications, a patient with a platelet count >70×109/L and normal platelet function should be a candidate for a neuraxial procedure. Coagulation testing is not routine in preeclamptic women. Previous data and guidelines on the relationship between coagulation testing and risk of complications from neuraxial procedures are inconsistent. This study aimed to better understand the use of coagulation testing in patients with preeclampsia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
